share_log

HC Wainwright & Co. Reiterates Buy on IO Biotech, Maintains $12 Price Target

HC Wainwright & Co. Reiterates Buy on IO Biotech, Maintains $12 Price Target

HC Wainwright&Co.重申對IO Biotech的買入評級,維持12美元的目標價
Benzinga ·  09/16 07:27  · 評級/大行評級

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $12 price target.

HC Wainwright & Co.分析師Emily Bodnar重申買入IO Biotech (NASDAQ:IOBT),維持12美元的價格目標。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論